Methyldopa anhydrous
Methyldopa anhydrous Brand names, Methyldopa anhydrous Analogs
- AMD
- Aldoclor-150
- Aldoclor-250
- Aldomet
- Aldometil
- Aldomin
- Aldoril 15
- Aldoril 25
- Aldoril D30
- Aldoril D50
- Alpha medopa
- Alphamethyldopa
- Apo-Methyldopa
- Bayer 1440 L
- Baypresol
- Becanta
- Dopamet
- Dopamethyperpax
- Dopatec
- Dopegyt
- Grospisk
- Hyperpax
- Hypolag
- L-Methyl Dopa
- Medomet
- Medopa
- Medopal
- Medopren
- Methoplain
- Methyldopa anhydrous
- Methyldopate
- Methyldopate HCL
- Mk. b51
- Novomedopa
- Nu-Medopa
- Presinol
- Presolisin
- Sedometil
- Sembrina
Methyldopa anhydrous Brand Names Mixture
- No information avaliable
Methyldopa anhydrous Chemical_Formula
C56H71N9O23S
Methyldopa anhydrous RX_link
http://www.rxlist.com/cgi/generic4/mycamine.htm
Methyldopa anhydrous fda sheet
Methyldopa anhydrous msds (material safety sheet)
Methyldopa anhydrous Synthesis Reference
No information avaliable
Methyldopa anhydrous Molecular Weight
1270.28 g/mol
Methyldopa anhydrous Melting Point
No information avaliable
Methyldopa anhydrous H2O Solubility
Freely soluble as sodium salt (> 200mg/mL)
Methyldopa anhydrous State
Solid
Methyldopa anhydrous LogP
No information avaliable
Methyldopa anhydrous Dosage Forms
Powder for solution (for injection)
Methyldopa anhydrous Indication
For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.
Methyldopa anhydrous Pharmacology
Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.
Methyldopa anhydrous Absorption
No information avaliable
Methyldopa anhydrous side effects and Toxicity
Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.
Methyldopa anhydrous Patient Information
No information avaliable
Methyldopa anhydrous Organisms Affected
Aspergillis, Candida and other fungi
